National Health Investors, Inc. (NYSE:NHI) Declares $0.90 Quarterly Dividend

National Health Investors, Inc. (NYSE:NHI) declared a quarterly dividend on Tuesday, November 5th, Wall Street Journal reports. Investors of record on Tuesday, December 31st will be given a dividend of 0.90 per share by the real estate investment trust on Wednesday, January 29th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.69%. The ex-dividend date is Tuesday, December 31st.

National Health Investors has raised its dividend by an average of 0.9% per year over the last three years. National Health Investors has a dividend payout ratio of 115.0% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Analysts expect National Health Investors to earn $4.66 per share next year, which means the company should continue to be able to cover its $3.60 annual dividend with an expected future payout ratio of 77.3%.

National Health Investors Stock Up 0.0 %

NHI opened at $76.76 on Thursday. The company has a debt-to-equity ratio of 0.91, a current ratio of 10.27 and a quick ratio of 10.27. The company’s 50-day moving average is $80.38 and its 200 day moving average is $73.16. National Health Investors has a fifty-two week low of $49.25 and a fifty-two week high of $86.13. The firm has a market capitalization of $3.34 billion, a P/E ratio of 26.11, a PEG ratio of 5.05 and a beta of 1.05.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.42). The company had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The business’s revenue was up 1.7% on a year-over-year basis. During the same period in the prior year, the firm posted $1.08 EPS. Research analysts expect that National Health Investors will post 4.48 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Truist Financial lifted their target price on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research note on Friday, August 30th. Bank of America began coverage on shares of National Health Investors in a research note on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective for the company. Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their price objective for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Finally, StockNews.com cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, National Health Investors presently has a consensus rating of “Moderate Buy” and an average price target of $73.29.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.